{
    "title": "Wegovy class has higher GI side effect risk than older weight loss drug in study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12599323/Wegovy-class-higher-GI-effect-risk-older-weight-loss-drug-study.html",
    "date": "2023-10-05",
    "keywords": [
        "wegovy",
        "drug",
        "stomach",
        "pancreatitis",
        "paralysis",
        "study",
        "ingredient",
        "wingrove",
        "class",
        "risk",
        "blockage",
        "obesity",
        "nordisk",
        "mounjaro",
        "loss",
        "year",
        "food",
        "therapy",
        "thursday",
        "bupropionnaltrexone",
        "report",
        "jama",
        "journal",
        "contrave",
        "glp1",
        "rybelsus",
        "companys",
        "medicine",
        "saxenda",
        "victoza",
        "liraglutide",
        "condition",
        "semaglutide",
        "number",
        "spokesperson",
        "failure",
        "passage",
        "administration",
        "use",
        "weight",
        "riskbenefit",
        "calculus",
        "group",
        "studys",
        "month",
        "fda",
        "label",
        "ozempic",
        "potential",
        "side",
        "effect",
        "reporting",
        "editing",
        "nancy",
        "lapid",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}